LAKEWOOD, Colo.--(BUSINESS WIRE)--June 13, 2006--CeraPedics, a privately held company focused on the development of synthetic bone graft products incorporating its proprietary P-15(TM) technology, announced today that the results from a pilot study for the treatment of non-union and delayed union fractures have been published in the International Orthopaedics journal. The purpose of the study was to assess the feasibility and clinical outcome of using CeraPedics’ P-15 bone graft substitute (P-15 BGS) to treat non-union and delayed union fractures.
